Page results
-
During your care at UCLH your clinician may order tests for you. We carry out thousands of different tests a year and know that waiting for results can be a difficult time.
-
Our Proton Beam Therapy (PBT) department can treat up to 650 NHS patients per year from across the south of the UK when we are at full capacity. We provide treatment for a wide range of child and teenage cancers and complex adult cancers.
-
Professor Lunn's specialist clinical and research interests are in the inflammatory neuropathies, particularly Guillain-Barré syndrome, CIDP and paraproteinaemic neuropathies.
-
This page explains what you can expect during recovery from your CAR T-cell therapy.
-
Our mission is to provide state-of-the-art, high-quality, evidence-based and patient-centred treatment for the management of all grades of endometriosis.
-
Information about sickle cell disorder in adulthood for UCLH patients.
-
This page is for parents and carers of children with sickle cell disease. It explains what happens during a Transcranial Doppler Scan.
-
The department provides a unique and highly specialised clinical neuropsychological diagnostic and therapeutic service for in- and outpatients.
-
The Lysholm Department of Neuroradiology is a multidisciplinary team of healthcare professionals providing leading-edge neuroradiological services, performing around 60,000 examinations and procedures per year.
-
Our Brain Tumour Service is a pioneering specialist centre offering high-quality treatment and care to patients with all forms of brain or spinal tumours.
File results
-
FOI/2024/0573 - Treatment for haemophilia A and B/ von Willebrand patients
-
FOI/2024/0575 - Replacement or purchase of patient trolleys in 2024/25
-
FOI/2022/0780 - Hereditary Angioedema (HAE) service
-
FOI/2024/0446 - Skin cancer treatment times 2019/20-2023/24
-
FOI/2024/0458 - Infected blood products, patient numbers 2019/20-2023/24
-
FOI/2024/0577 - Diffuse Large B Cell Lymphoma treatments
-
FOI/2024/0582 - SACT (systemic anti-cancer therapy) treatments for endometrial cancer
-
FOI/2024/0584 - Immunology Hidradenitis Suppurativa (HS) treatments
-
FOI/2024/0583 - National inpatient survey improvements/ night-time noise levels/ ward lighting/ mealtime support
-
FOI/2024/0570 - Pathway for genetic/ genomic testing for MND